Monoclonal Antibodies (mAbs)
Recently, the Indian Council of Medical Research (ICMR) invited Expressions of Interest for developing and producing monoclonal antibodies (mAbs) as a countermeasure against Nipah virus, which continues to trigger repeated outbreaks in India.
- “Monoclonal antibodies” refers to lab-engineered antibodies that are designed to mimic natural immune antibodies by specifically recognising and neutralising a particular pathogen or antigen.
- It means that a single, identical antibody type is produced in large quantities to target one specific protein on a virus, offering precise and powerful protection or treatment.
- ICMR stressed that due to the absence of licensed vaccines and the high fatality rate of Nipah virus, ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Science & Technology
- 1 China’s EAST Reactor Breaks a Key Fusion Barrier
- 2 BSL-4 Containment Facility in Gandhinagar
- 3 Aditya-L1 Provides New Insights on Earth’s Magnetic Shield
- 4 India’s First Commercial Earth Observation Satellite Constellation
- 5 Why a ‘Cosmic Dust Particle’ Hits Earth Every 16 Minutes
- 6 Salvo Test of ‘Pralay’ Missile
- 7 DRDO Successfully Tests Indigenous MPATGM
- 8 DRDO’s Long-Duration Scramjet Test
- 9 Indian Army Signs Deal for ‘Suryastra’
- 10 LR-AShM at Republic Day Parade
